New tech requires a period of acceptance. This is even more so in the medical space.
If you have something that has worked for so long, and all practitioners are trained in it and it is accepted in the industry, would a hospital board risk introducing something different?
Invasive monitoring has always been the standard of care. That is only just beginning to change. Acceptance for non invasive methods is growing and USCOM is the leader in that area.
The above coupled with confused distribution channels and sales models. They have worked intensely on this the past year.
At the end of the day, the numbers will do the taking and thus far, from all that has been disclosed, we are clearly on track for a record quarter.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable